Search Within

Heiko Schoder

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (27)
  2. Gastrointestinal Oncology Service (27)
  3. Molecular Imaging and Therapy Service (27)
  4. Radiology, Department of (27)
  5. Solid Tumor Oncology Division (27)
  6. Center for Pancreatic Cancer Research (25)

More Groups

People
  1. Yelena Janjigian (16)
  2. Marinela Capanu (12)
  3. Daniel Coit (10)
  4. Vivian Strong (10)
  5. Laura Tang (9)
  6. David Ilson (7)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Journal of Nuclear Medicine (5)
  3. Annals of Surgical Oncology (2)
  4. Pancreas (2)
  5. Annals of Surgery (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Society of Nuclear Medicine (5)
  3. Springer (4)
  4. Lippincott Williams & Wilkins (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma
    Journal Article

    White, C.; Jayaprakasam, V. S.; Tenet, M.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Maron, S. B.; Schöder, H.; Larson, S. M.; Gönen, M.; more...
    European Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Patient metabolic profile defined by liver and muscle (18)F-FDG PET avidity is independently associated with overall survival in gastric cancer
    Journal Article

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Ku, G. Y.; Maron, S. B.; Schoder, H.; Larson, S. M.; Gönen, M.; more...
    Gastric Cancer (2024)

    Fulltext@MSK | Save
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schöder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient metabolic profiles defined by liver and muscle 18F-FDG PET avidity are independently associated with overall survival in gastric cancer
    Meeting Abstract

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L.; Schattner, M.; Janjigian, Y.; Ku, G.; Maron, S.; Schoder, H.; Larson, S.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save